SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

FERMISCAN HOLDINGS LIMITED (FER)

Former Name ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
TEMPO AUSTRALIA LTD21/06/2012
FERMISCAN HOLDINGS LIMITED17/10/200621/06/2012
OLYMPUS RESOURCES LIMITED07/08/198617/10/2006
OLYMPUS PETROLEUM NL15/01/197007/08/1986
WEATHERLY OIL NL15/01/1970

Shareholder links

 

REGISTRY:

Link Market Services, Rhodes Corporate Park, 1A Homebush Bay Drive, Rhodes NSW 2138

Tel : +61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: C/- Level 29, 66 Goulburn Street, SYDNEY, NSW, AUSTRALIA, 2000
Tel:  (02) 8263 4000 Fax: (02) 8263 4111

Date first listed: 04/12/1980
Company Secretary: John Rainbow
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Share trading and investment in companies involved in telecommunications and property development
OFX Transferring Money Internationally to Free

name changed to Tempo Australia Ltd (TPP)

21/06/2012

we understand that on or about this date the company consolidated its shares 1 for 10

19/06/2012

The securities of Fermiscan Holdings Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, following the receipt of shareholder approval for the proposed acquisition of Industry Partners Pty Ltd and Immigration Partners Pty Ltd. In accordance with ASX" requirements for compliance with Chapter 11 of the Listing Rules, the Company" securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules

31/05/2012

the suspension of trading in the securities of Fermiscan Holdings Limited (the "Company") will be lifted immediately, following the Company's compliance with Chapter 12 of the ASX Listing Rules

23/03/2011

company advises that as a result of the terms of the convertible note issue being satisfied that the convertible notes have converted and as a result the 150,000,000 ordinary shares have been issued to the note holders

14/03/2011

the Directors of the company advise that the rights issue closed as provided in the prospectus at 5.00pm (Sydney time) 3 March 2011. $75,429.89 was received with subscriptions for 7,542,989 shares. There have been further subscriptions for 16,100,000 shares under the shortfall facility with $161,000 received. Additionally there have been 9 late applications for an additional 354,525 shares, with $3,545.25 received, such applications will be dealt with under the shortfall facility. It is noted that the prospectus provides that the shortfall facility remains open for three (3) months past the closure of the offer. The Directors have resolved that applications for shares under the shortfall facility will be dealt with on a first come first served basis

04/03/2011

company confirms that dispatch of the non-renounceable Rights Issue Replacement Prospectus dated 10 February 2011 together with personalised Entitlement and Acceptance Forms has been completed today

17/02/2011

issues Replacement Prospectus

11/02/2011

Fermiscan has formed the view that it is unreasonable to extend the Rights Issue to shareholders outside of Australia, and that the offer pursuant to the Rights Issue will only be extended to Fermiscan shareholders on record at 5pm 14 February 2011 with registered addresses within Australia

08/02/2011

Fermiscan Holdings Limited (Fermiscan or Company) (ASX:FER) today lodged a prospectus with ASX regarding a Non-Renounceable Rights Issue (Rights Issue) to raise up to approximately $767,533. Under the Rights Issue, eligible shareholders will be invited to subscribe for 1 new share for every 2 shares held at the record date at an offer price of $0.01 per share (the Prospectus and Entitlement and Acceptance Form pursuant to the Non- Renounceable Rights Issue will be mailed to shareholders on 17 February 2011. The closing date for acceptance is 3 March 2011)

07/02/2011

releases a Non-Renounceable Issue Prospectus

04/02/2011

enters into a MOU to continue Synchrotron trials

23/12/2010

releases Half Yearly Report

16/12/2010

all resolutions at today's AGM were passed on a show of hands

30/11/2010

a rights issue (to raise $767k) is coming up

23/11/2010

releases Notice of Annual General Meeting

01/11/2010

plans the AGM for 30 Nov

27/10/2010

releases Full Year Accounts

01/10/2010

expects reinstatement to quotation to be 6 to 8 weeks away

20/09/2010

provides update - it expects to make an announcement regarding a restructuring in due course

16/08/2010

responds to ASX queries

05/07/2010

Deed of Company Arrangement was terminated today

11/06/2010

the sale of the intellectual property and certain assets for the sum of $250,000 plus GST to SBC Research Pty Limited, an unrelated third party, has now been settled

04/05/2010

Deed of Company Arrangement is released

26/03/2010

the Deed of Company Arrangement was executed today

08/03/2010

releases Preliminary Final Report

26/02/2010

creditors resolve that the company execute a Deed of Company Arrangement

16/02/2010

administrator is assessing a number of offers for the assets of the company or to invest in the company

15/01/2010

the administrator's report to creditors is available at www.woodgate.com.au

15/12/2009

Giles Geoffrey Woodgate of Woodgate & Co., Chartered Accountant, is appointed administrator - this never augurs well for shareholders but it will be several weeks before the administrator acquaints the market with the financial position - shareholders should be aware that they may crystallise a capital loss if they wish by utilising our online worthless shares facility

18/11/2009

Fermiscan advised in May 2009 and in June 2009 of litigation with Dr James, the inventor of the Fermiscan patent "Using hair to Screen for Breast Cancer". Dr James had filed a new patent using x-ray diffraction of fingernails and skin instead of hair for the detection of breast cancer. Fermiscan had received advice that the new patent is the property of Fermiscan and was pursuing the matter Court. On 29 May 2009, in the original hearing, the Judge handed down his judgment which was that Dr James was not obliged to transfer that new patent to Fermiscan, and awarded costs against Fermiscan. Fermiscan appealed this decision and today the New South Wales Court of Appeal dismissed with costs the Fermiscan appeal in relation to the new patents. The board expects the exposure to Dr James for costs on both the original hearing and the appeal could aggregate in excess of $500,000. The board is taking advice and considering the implications of this court decision

11/11/2009

the securities of Fermiscan Holdings Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending an announcement with regard to the completion of an agreement in relation to the Company's business

28/10/2009

shares reinstated to quotation

25/10/2006

name changed from Olympus Resources Limited

17/10/2006

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    30/05/2012Peter Dykes3,208,642$0.020$62,653
    30/05/2012Richard Wright3,569,631$0.018$65,253
    24/05/2012Peter Dykes1,000,000$0.018$18,209
    22/05/2012Carmelo Bontempo1,775,519$0.017$30,542
    14/05/2012Peter Dykes1,391,358$0.018$25,095

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Robert WhittonChairman20/08/2010
    Giuseppe LeoneCOO23/01/2012
    Richard WrightDirector03/08/2011
    Carmelo BontempoDirector03/08/2011
    Peter DykesDirector17/03/2011

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.